Stephens Consulting’s Zimmer Biomet ZBH Stock Holding History

Stephens Consulting’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10	Closed	-$913	–	1200
2025 Q2	$913	Sell	10 -190	-95%	-$18.4K	﹤0.01%	705
2025 Q1	$22.6K	Hold	200	–	–	0.01%	252
2024 Q4	$21.1K	Hold	200	–	–	0.01%	276
2024 Q3	$21.6K	Hold	200	–	–	0.01%	255
2024 Q2	$21.7K	Hold	200	–	–	0.01%	256
2024 Q1	$26.4K	Hold	200	–	–	0.01%	228
2023 Q4	$24.3K	Hold	200	–	–	0.01%	232
2023 Q3	$22.4K	Hold	200	–	–	0.01%	238
2023 Q2	$29.1K	Hold	200	–	–	0.01%	214
2023 Q1	$25.8K	Hold	200	–	–	0.02%	227
2022 Q4	$25.5K	Hold	200	–	–	0.02%	219
2022 Q3	$20.9K	Hold	200	–	–	0.02%	248
2022 Q2	$21K	Hold	200	–	–	0.02%	240
2022 Q1	$25.6K	Sell	200 -6	-3%	-$723	0.02%	250
2021 Q4	$25.4K	Buy	+206	New	+$27K	0.02%	272

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Stephens Consulting's ZBH Position: Q3 2025 in Review

Stephens Consulting sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 10 shares — an estimated $913 sold.

Stephens Consulting first reported a position in ZBH in Q4 2021 and held it in 15 quarters. The position peaked at $29.1K in Q2 2023. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.

Stephens Consulting reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
Stephens Consulting sold 10 Zimmer Biomet shares in Q3 2025, an estimated $913.
Stephens Consulting first reported a position in Zimmer Biomet in Q4 2021 and held it in 15 quarters.
Stephens Consulting's Zimmer Biomet position peaked at $29.1K in Q2 2023.
966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.

Based on Stephens Consulting's 13F filing for Q3 2025, filed 15 Oct 2025.